Publications by authors named "Tim M Jenkins"

Claim this Profile
P
Phase II study of avatrombopag in thrombocytopenic patients with cirrhosis undergoing an elective procedure.
Norah A Terrault, Tarek Hassanein, Charles D Howell, Shobha Joshi, John Lake, Tim M Jenkins

J Hepatol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient assessment of efficacy in post-traumatic peripheral neuropathic pain patients: pregabalin in a randomized, placebo-controlled, crossover study.
Tim M Jenkins, Trevor S Smart, Frances Hackman, Carol Cooke, Keith Kc Tan

J Pain Res· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity, pharmacokinetics and safety of lersivirine (UK-453,061), a next-generation nonnucleoside reverse transcriptase inhibitor, during 7-day monotherapy in HIV-1-infected patients.
Gerd Fätkenheuer, Schlomo Staszewski, Andreas Plettenburg, Frances Hackman, Gary Layton, Tim M Jenkins

AIDS· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emergence of CXCR4-using human immunodeficiency virus type 1 (HIV-1) variants in a minority of HIV-1-infected patients following treatment with the CCR5 antagonist maraviroc is from a pretreatment CXCR4-using virus reservoir.
Mike Westby, Marilyn Lewis, Jeannette Whitcomb, Mike Youle, Anton L Pozniak, Tim M Jenkins

J Virol· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1.
Gerd Fätkenheuer, Anton L Pozniak, Margaret A Johnson, Andreas Plettenberg, Schlomo Staszewski, Tim M Jenkins

Nat Med· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis